Singapore markets closed

LLY Jun 2024 750.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
64.700.00 (0.00%)
As of 03:44PM EDT. Market open.
Full screen
Previous close64.70
Open65.40
Bid0.00
Ask0.00
Strike750.00
Expiry date2024-06-21
Day's range64.70 - 66.68
Contract rangeN/A
Volume51
Open interest888
  • Reuters

    Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows

    As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s. "It is very unusual to have a medicine that is capturing the imagination of millions of people," said Michael Kleinrock, senior research director at healthcare analytics firm IQVIA Institute for Data Science. Most insurers do not cover the new therapies with low co-payments, but an unprecedented percentage of people are paying themselves or with coupons from drug manufacturers, he said.

  • Zacks

    Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound

    Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.

  • Insider Monkey

    The Biggest Publicly Traded Biotech Company

    In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]